These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 1348753

  • 1. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G, Parente F.
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [Abstract] [Full Text] [Related]

  • 2. Drugs for treatment of peptic ulcers.
    Dajani EZ, Trotman BW.
    J Assoc Acad Minor Phys; 1992 Apr; 3(3):78-88. PubMed ID: 1353999
    [Abstract] [Full Text] [Related]

  • 3. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B.
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11 Suppl 1():113-6. PubMed ID: 2657280
    [Abstract] [Full Text] [Related]

  • 4. Medical treatment of peptic ulcers.
    Deveney CW, Deveney KE.
    Surg Annu; 1985 Apr; 17():219-33. PubMed ID: 3883541
    [Abstract] [Full Text] [Related]

  • 5. Site-and cytoprotective drugs in the short-term treatment of peptic ulcer. What is their current role?
    Bianchi Porro G, Parente F.
    Ital J Gastroenterol; 1990 Apr; 22 Suppl 1():5-10. PubMed ID: 1983422
    [Abstract] [Full Text] [Related]

  • 6. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN, Nio CY.
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [Abstract] [Full Text] [Related]

  • 7. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 8. Longer relapse-free period after sucralfate than after H2-blocker treatment of duodenal and gastric ulcers.
    Domschke S, Domschke W.
    Am J Med; 1991 Aug 08; 91(2A):74S-83S. PubMed ID: 1679297
    [Abstract] [Full Text] [Related]

  • 9. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 15; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 11. Role of protective drugs in the prevention of ulcer relapse.
    Ota S, Terano A.
    J Gastroenterol; 1994 Jul 15; 29 Suppl 7():139-40. PubMed ID: 7921147
    [Abstract] [Full Text] [Related]

  • 12. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990 Jul 15; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 15; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 14. Medical treatment of peptic ulcer disease.
    Andersen BN.
    Acta Chir Scand Suppl; 1988 Dec 15; 547():88-92. PubMed ID: 2906493
    [Abstract] [Full Text] [Related]

  • 15. Drugs for treatment of peptic ulcers.
    Med Lett Drugs Ther; 1991 Nov 29; 33(858):111-4. PubMed ID: 1682791
    [No Abstract] [Full Text] [Related]

  • 16. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M, Sainaghi M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov 29; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [Abstract] [Full Text] [Related]

  • 17. Refractory peptic ulcers.
    Arakawa T, Kobayashi K, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Nov 29; 3(3):95-102. PubMed ID: 1386767
    [Abstract] [Full Text] [Related]

  • 18. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct 29; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.